Metropolitan Anchor Hospitals
For 25 years, the 340B drug savings program, at no cost to the government, has enabled eligible hospitals to purchase certain outpatient drugs from pharmaceutical manufacturers at discounted prices. This allows the participating hospitals to use the savings from the discounts to provide an expanded鈥
A coalition of 35 national organizations, including the AHA, today urged House and Senate leaders to 鈥減rotect in full鈥 the current federal income tax treatment of private activity bonds, as envisioned by the Senate version of the Tax Cuts and Jobs Act.
A bipartisan group of six senators yesterday urged Senate leadership to include in a year-end package, legislation that would prevent a dramatic reduction in Medicare Part B payments for certain hospitals that participate in the 340B drug savings program. The Centers for Medicare & Medicaid鈥
The Senate voted 51-49 early Saturday to approve tax reform legislation, which includes provisions that would repeal enforcement of the Affordable Care Act mandate that most individuals have health insurance, eliminate hospitals鈥 ability to access low-cost capital financing through advance鈥
The CMS Nov. 30 issued a final rule cancelling the cardiac and surgical hip and femur fracture treatment bundled payment models.
The Health Resources and Services Administration is reminding hospitals that participate in the 340B drug savings program that they must recertify by Dec. 6 or they will be terminated from the program. HRSA is required to recertify annually all participating covered entities enrolled in the 340B鈥
Twenty-one House Republicans yesterday sent a letter spearheaded by Rep. Randy Hultgren (R-IL) to House and Senate leadership urging them to preserve the tax-exempt status of private-activity bonds and advance refundings of outstanding tax-exempt bonds in any tax reform legislation. 鈥淧rivate鈥
The Senate Budget Committee today voted 12-11 along party lines to approve the Tax Cuts and Jobs Act of 2017, a